amylin-amide has been implicated in the pathogenesis of type ii diabetes due to its proposed inhibitory effect on insulin release from beta cells of the pancreatic islets , and on glucose uptake by the skeletal muscle .
C0011860
type ii diabetes
C0021641
insulin